Staph bacteria may worsen eczema and trigger dangerous infections

NCT ID NCT04274348

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at how staphylococcus bacteria on the skin affect inflammation and immune responses in people with moderate to severe atopic dermatitis (eczema). Researchers took skin biopsies and blood samples from 41 adults to measure bacterial toxins and immune cell activity. The goal was to understand why some eczema patients develop serious viral skin infections like eczema herpeticum. This was an observational study, not a treatment trial, so it aims to uncover disease mechanisms rather than test a new therapy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this research could help explain why some people with eczema develop severe skin infections, pointing toward new ways to prevent or treat those complications.
What could go wrong
This is a small, completed observational study, not a treatment trial. It aims to understand the disease, not test a therapy, so it won't directly lead to a new drug or cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU de Bordeaux

    Bordeaux, France

  • CHU de Poitiers

    Poitiers, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.